Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 1034Neoplasms 815Carcinoma, Non-Small-Cell Lung 799Prostatic Neoplasms 621Colorectal Neoplasms 529Lung Neoplasms 486Neoplasm Metastasis 434Multiple Myeloma 395Leukemia, Myeloid, Acute 391Ovarian Neoplasms 334Pancreatic Neoplasms 316Melanoma 297Squamous Cell Carcinoma of Head and Neck 268Recurrence 256Carcinoma, Hepatocellular 250Glioblastoma 238Brain Neoplasms 237Triple Negative Breast Neoplasms 213Carcinoma, Renal Cell 209Head and Neck Neoplasms 208Precursor Cell Lymphoblastic Leukemia-Lymphoma 201Lymphoma 201Stomach Neoplasms 197Endometrial Neoplasms 189Uterine Cervical Neoplasms 185Lymphoma, Non-Hodgkin 180Glioma 180Sarcoma 179Lymphoma, Large B-Cell, Diffuse 167Hematologic Neoplasms 162

Interventions

talimogene laherparepvec 1exemestane 1Tamoxifen 1Surgical Procedures, Operative 1Specimen Handling 1Paclitaxel 1Mastectomy, Segmental 1Letrozole 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Ductal × 90 days × Clear all
NCT05183828 2026-06-04

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

University of Washington

Phase 4 Terminated
62 enrolled

Carcinoma, Ductal

NCT02926911 2026-05-12

COMET

Alliance Foundation Trials, LLC.

Phase NA Active not recruiting
997 enrolled 16 charts
Breast

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
140 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal

NCT00185744 2026-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

Stanford University

Phase NA Active not recruiting
121 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal

NCT02779855 2026-03-10

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Completed
50 enrolled 12 charts
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Ductal, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡